C. David Sjöström - Publications, H-index & Citations

C. David Sjöström

AstraZeneca

53H指数

207论文数

2.5W被引数

收录论文 70

发表时间

Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis 达格列净对伴有肝纤维化风险的2型糖尿病患者心血管结局的影响

diabetes, obesity and metabolism

IF0

2026-04-27

OAAI

Jan Oscarsson; Monika Huhn; Yunyun Jiang; Ingrid Gause-Nilsson; Stephen D. Wiviott; Filipe A. Moura; John P. H. Wilding; Simona Cernea; Luc Van Gaal; Avivit Cahn; Deepak L. Bhatt; Peter A. Johansson; C. David Sjöström

Protein profiles and associated biological pathways among different aetiologies of chronic kidney disease: new insights from DAPA-CKD 不同慢性肾病病因的蛋白质谱及关联生物学通路：DAPA-CKD研究的新见解

Nephrology Dialysis Transplantation

IF5.6

2025-10-01

OAAI

de la Rambelje, M. Andre; Beldhuis, Iris E.; Heerspink, Hiddo J. L.; Greasley, Peter J.; Agren, Rasmus; Hammarstedt, Ann; Sjostrom, C. David; Voors, Adriaan A.; Jongs, Niels

Effects of Dapagliflozin on Progression of CKD According to Different Rates of Pretrial eGFR Loss 达格列净对不同基线eGFR下降速率的CKD进展的影响

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2025-09-01

OAAI

Heerspink, Hiddo J. L.; Chertow, Glenn M.; Rossing, Peter; Correa-Rotter, Ricardo; Sjostrom, C. David; Toto, Robert D.; Wheeler, David C.; Jongs, Niels

Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial Verinurad联合别嘌呤醇治疗射血分数保留的心力衰竭: 紫水晶随机临床试验

JAMA CARDIOLOGY

IF14.1

2024-10-01

PREAI

Kitzman, Dalane W.; Voors, Adriaan A.; Mentz, Robert J.; Lewis, Gregory D.; Perl, Shira; Myte, Robin; Kaguthi, Grace; Sjoestroem, C. David; Kallgren, Christian; Shah, Sanjiv J.

Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes

JCI INSIGHT

IF6.1

2023-09-08

OAAI

Regan, Jessica A.; Mentz, Robert J.; Nguyen, Maggie; Green, Jennifer B.; Truby, Lauren K.; Ilkayeva, Olga; Newgard, Christopher B.; Buse, John B.; Sourij, Harald; Sjostrom, C. David; Sattar, Naveed; Mcgarrah, Robert W.; Zheng, Yinggan; Mcguire, Darren K.; Standl, Eberhard; Armstrong, Paul; Peterson, Eric D.; Hernandez, Adrian F.; Holman, Rury R.; Shah, Svati H.

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2023-05-02

OAAI

Chertow, Glenn M.; Correa-Rotter, Ricardo; Vart, Priya; Jongs, Niels; McMurray, John J. V.; Rossing, Peter; Langkilde, Anna Maria; Sjostrom, C. David; Toto, Robert D.; Wheeler, David C.; Heerspink, Hiddo J. L.

Perspectives in weight control in diabetes-SGLT2 inhibitors and GLP-1-glucagon dual agonism

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2023-05-01

PREAI

Iqbal, Nayyar; Ambery, Philip; Logue, Jennifer; Mallappa, Ashwini; Sjostrom, C. David

Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross-over clinical study

DIABETES OBESITY & METABOLISM

IF5.7

2023-03-13

OAAI

van der Aart-van Der Beek, Annemarie B.; Apperloo, Ellen; Jongs, Niels; Rouw, Dennis B.; Sjostrom, C. David; Friedli, Iris; Johansson, Lars; van Raalte, Daniel H.; Hoogenberg, Klaas; Heerspink, Hiddo J. L.

Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

DIABETES CARE

IF16.6

2023-01-20

OAAI

Beernink, Jelle M.; Persson, Frederik; Jongs, Niels; Laverman, Gozewijn D.; Chertow, Glenn M.; McMurray, John J. V.; Langkilde, Anna Maria; Correa-Rotter, Ricardo; Rossing, Peter; Sjostrom, C. David; Toto, Robert D.; Wheeler, David C.; Heerspink, Hiddo J. L.

Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease: A Post Hoc Analysis of DAPA-CKD

ANNALS OF INTERNAL MEDICINE

IF15.2

2023-01-01

OAAI

Schechter, Meir; Jongs, Niels; Chertow, Glenn M.; Mosenzon, Ofri; McMurray, John J., V; Correa-Rotter, Ricardo; Rossing, Peter; Langkilde, Anna Maria; Sjostrom, C. David; Toto, Robert D.; Wheeler, David C.; Heerspink, Hiddo J. L.

Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2022-11-01

OAAI

Heerspink, Hiddo J. L.; Chertow, Glenn M.; Jongs, Niels; Correa-Rotter, Ricardo; Rossing, Peter; Sjostrom, C. David; Langkilde, Anna Maria; Wheeler, David C.

Once-Weekly Exenatide in Youth With Type 2 Diabetes

DIABETES CARE

IF16.6

2022-07-26

OAAI

Tamborlane, William, V; Bishai, Raafat; Geller, David; Shehadeh, Naim; Al-Abdulrazzaq, Dalia; Manica Vazquez, Evelina; Karoly, Eva; Troja, Tunde; Doehring, Orlando; Carter, Debra; Monyak, John; Sjostrom, C. David

Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits

RADIOTHERAPY AND ONCOLOGY

IF5.3

2022-06-01

OAAI

Astrom, Lina M.; Behrens, Claus P.; Calmels, Lucie; Sjostrom, David; Geertsen, Poul; Mouritsen, Lene Sonne; Serup-Hansen, Eva; Lindberg, Henriette; Sibolt, Patrik

Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions

KIDNEY INTERNATIONAL REPORTS

IF5.7

2022-04-01

OAAI

Vart, Priya; Correa-Rotter, Ricardo; Hou, Fan Fan; Jongs, Niels; Chertow, Glenn M.; Langkilde, Anna Maria; McMurray, John J., V; Rossing, Peter; Sjostrom, C. David; Stefansson, Bergur, V; Toto, Robert D.; Douthat, Walter; Escudero, Elizabeth; Isidto, Rey; Khullar, Dinesh; Bajaj, Harpreet S.; Wheeler, David C.; Heerspink, Hiddo J. L.

The Kidney Protective Effects of the Sodium-Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists

KIDNEY INTERNATIONAL REPORTS

IF5.7

2022-03-01

OAAI

Provenzano, Michele; Jongs, Niels; Vart, Priya; Stefansson, Bergur, V; Chertow, Glenn M.; Langkilde, Anna Maria; McMurray, John J., V; Correa-Rotter, Ricardo; Rossing, Peter; Sjostrom, C. David; Toto, Robert D.; Wheeler, David C.; Heerspink, Hiddo J. L.

Quetelet (body mass) index and effects of dapagliflozin in chronic kidney disease

DIABETES OBESITY & METABOLISM

IF5.7

2022-02-16

OAAI

Chertow, Glenn M.; Vart, Priya; Jongs, Niels; Langkilde, Anna Maria; McMurray, John J., V; Correa-Rotter, Ricardo; Rossing, Peter; Sjostrom, C. David; Stefansson, Bergur, V; Toto, Robert D.; Wheeler, David C.; Heerspink, Hiddo J. L.

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function 关于肾功能突然下降发生率的达格列净和预防慢性肾脏病不良结局 (DAPA-CKD) 随机对照试验的预先指定分析

KIDNEY INTERNATIONAL

IF12.6

2022-01-01

OAAI

Heerspink, Hiddo J. L.; Cherney, David; Postmus, Douwe; Stefansson, Bergur, V; Chertow, Glenn M.; Dwyer, Jamie P.; Greene, Tom; Kosiborod, Mikhail; Langkilde, Anna Maria; McMurray, John J., V; Correa-Rotter, Ricardo; Rossing, Peter; Sjostrom, C. David; Toto, Robert D.; Wheeler, David C.

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

KIDNEY INTERNATIONAL

IF12.6

2021-07-01

221

OAAI

Wheeler, David C.; Toto, Robert D.; Stefansson, Bergur V.; Jongs, Niels; Chertow, Glenn M.; Greene, Tom; Hou, Fan Fan; McMurray, John J. V.; Pecoits-Filho, Roberto; Correa-Rotter, Ricardo; Rossing, Peter; Sjostrom, C. David; Umanath, Kausik; Langkilde, Anna Maria; Heerspink, Hiddo J. L.

Once-Weekly Exenatide in Youth with Type 2 Diabetes: A Pivotal Phase III Randomized Study

DIABETES

IF7.5

2021-06-01

PREAI

Tamborlane, William V.; Bishai, Raafat; Geller, David; Shehadeh, Naim; Al-Abdulrazzaq, Dalia; Karoly, Eva; Doehring, Orlando; Carter, Debra; Monyak, John; David Sjostrom, C.

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

EUROPEAN HEART JOURNAL

IF35.6

2021-04-01

OAAI

Heerspink, Hiddo J. L.; Sjostrom, C. David; Jongs, Niels; Chertow, Glenn M.; Kosiborod, Mikhail; Hou, Fan Fan; McMurray, John J., V; Rossing, Peter; Correa-Rotter, Ricardo; Kurlyandskaya, Raisa; Stefansson, Bergur, V; Toto, Robert D.; Langkilde, Anna Maria; Wheeler, David C.

研究方向